Ganymed Pharmaceuticals GmbH;TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gGmbH
发明人:
Sahin, Ugur,Türeci, Özlem,Walter, Korden,Kreuzberg, Maria,Mitnacht-Kraus, Rita,Le Gall, Fabrice,Jacobs, Stefan
申请号：
AU2016249782
公开号：
AU2016249782A1
申请日:
2016.04.13
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The present invention provides anti-CLDN18.2 antibody-drug conjugates which are effective for treating and/or preventing cancer diseases associated with cells expressing CLDN18.2, including gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.
